Sort   by:  
 Page size 
UnknownTandem CD19/CD22 CAR T-cells as potential therapy for children and young adults with high-risk r/r B-ALL.
Not available
S-EPMC12341234 | biostudies-literature
UnknownUnveiling the influence of CAR-negative T-cells: enhancing efficacy and ensuring safety in CAR-T therapies.
Not available
S-EPMC12366063 | biostudies-literature
UnknownThe Potential of the Gut Microbiota and Butyrate to Enhance CAR T-cell Therapy in Non-Hodgkin Lymphoma.
Not available
S-EPMC12809112 | biostudies-literature
UnknownA novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL.
Not available
S-EPMC8821938 | biostudies-literature
UnknownTransient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies.
Not available
S-EPMC10946657 | biostudies-literature
UnknownICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling.
Not available
S-EPMC12568627 | biostudies-literature
UnknownGeneration and GMP scale-up of human CAR-T cells using non-viral <i>Sleeping Beauty</i> transposons for B cell malignances.
Not available
S-EPMC11874549 | biostudies-literature
UnknownPersonalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Not available
S-EPMC10277746 | biostudies-literature
UnknownMeasuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.
Not available
S-EPMC5986687 | biostudies-literature
UnknownEvaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries.
Not available
S-EPMC10771257 | biostudies-literature
Sort   by:  
 Page size